All individuals in MeSH

Label Id Description
Premenstrual Dysphoric Disorder D065446 [A condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins. ]
Premenstrual Syndrome D011293 [A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses. , A term used to describe the psychological aspects of PREMENSTRUAL SYNDROME, such as the "indescribable tension", depression, hostility, and increased seizure activity in women with seizure disorder. ]
Prenalterol D011294 [A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute CARDIAC FAILURE, postmyocardial infarction low-output syndrome, SHOCK, and reducing ORTHOSTATIC HYPOTENSION in the SHY-RAGER SYNDROME. ]
Prenatal Care D011295 [Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. ]
Prenatal Diagnosis D011296 [Performing various procedures and tests on the EMBRYO; FETUS; or mother for the detection of diseases. , Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. ]
Prenatal Education D064186 [Preparing parents-to-be for CHILDBIRTH. , Training for pregnant women and parents-to-be to prepare for CHILDBIRTH; CHILD CARE; and parenthood. ]
Prenatal Exposure Delayed Effects D011297 [The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. ]
Prenatal Injuries D049188 [Damages to the EMBRYO, MAMMALIAN or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical. ]
Prenatal Nutritional Physiological Phenomena D039401 [Nutrition of FEMALE during PREGNANCY. ]
Prenylamine D011299 [A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1406) ]
Prenylation D054876 [Attachment of isoprenoids (TERPENES) to other compounds, especially PROTEINS and FLAVONOIDS. ]
Preoperative Care D011300 [Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) ]
Preoperative Exercise D000082622 [Various physical exercises implemented before a surgery designed for better TREATMENT OUTCOME. ]
Preoperative Period D057234 [The period before a surgical operation. ]
Preoptic Area D011301 [Region of hypothalamus between the ANTERIOR COMMISSURE and OPTIC CHIASM. ]
Prepaid Health Plans D017061 [Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium. ]
Prephenate Dehydratase D011302 [An enzyme that catalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. EC 4.2.1.51. ]
Prephenate Dehydrogenase D011303 [An enzyme that catalyzes the conversion of prephenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. EC 1.3.1.12. ]
Preprint D000076942 [Scientific manuscript made available prior to PEER REVIEW. ]
Preprints as Topic D000076682 [Works about scientific manuscripts made available prior to PEER REVIEW. ]